Formulation and evaluation of glipizide floating-bioadhesive tablets

Brazilian Archives of Biology and Technology

Volumn 53, Issue 5, 2010, Pages 1073-1085

  Patel, Jayvadan K ^a   Chavda, Jayant R ^b  

^a NOOTAN PHARMACY COLLEGE   (India)

^b B K Mody Government Pharmacy College   (India)

Author keywords

Floating bioadhesive; Glipizide; Non Fickian release; Tablets

Indexed keywords

EID: 78649361969     PISSN: 15168913     EISSN: 15168913     Source Type: Journal    
DOI: 10.1590/S1516-89132010000500014     Document Type: Article

References (47)

1. Ahuja A, Khar RK, Ali J (1997). Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm., 23(5):489-515.
2. Ali J, Khar RK, Ahuja A, Kalra R. (2002). Buccoadhesive erodible disk for treatment of oro-dental infections: Design and characterization. Int J Pharm., 238:93-103.
3. Alvisi V, Gasparetoo A, Dentale A. (1996). Bioavailability of a controlled release formulation of ursodeoxycholic acid in man. Drugs Exp. Clin. Res., 22:23-29.
4. Banakar UV. (1992). Pharmaceautical Dissolution Testing, 1st ed. New York:Marcel Dekker. 191-194.
5. Baumgartner S, Kristl J, Vrecer F, Vodopivec P, Zorko B. (2000). Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm., 195:125-135.
6. Bechgaard H, Ladefoged K. (1978). Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets. J. Pharm. Pharmacol., 30:690-692.
7. Chickering III DE, Mathiowitz E. (1999). Definitions, mechanisms and theories of bioadhesion, In Bioadhesive Drug Delivery Systems.Fundamental, Novel approaches, and Development, eds. Mathiowitz, E., Chickering III, D.E., and Lehr, C.M. New York: Marcel Dekker, pp 1-8.
8. Chitnis VS, Malshe VS, Lalla JK. (1991). Bioadhesive polymersynthesis, evaluation and application in controlled release tablets. Drug Dev.Ind. Pharm., 17(6): 879-892.
9. Chng HS, Park H, Kelly P, Robinson JR. (1985). Bioadhesive polymers as platforms for oral controlled drug delivery II: Synthesis and evaluation of some swelling water-insoluble bioadhesive polymers. J. Pharm. Sci., 74: 399-405.
10. Chowdary KPR, Rao YS. (2003). Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: a technical note. AAPSPharmSci Tech. 4: E39-E44.
11. Chueh HR, Zia H, Rhodes CT. (1995). Optimization of sotalol and bioadhesive extended-release tablet formulations. Drug Dev. Ind. Pharm., 21(15): 1725-1747.
12. Das NG, Das SK. (2003). Controlled-release of oral dosage forms. Pharm.Technol. 10-16.
13. Dave BS, Amin AF, Patel MM. (2004). Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS Pharm. Sci. Tech. 5(2): Article 34.
14. Davis SS, Stockwell AF, Taylor MJ. (1986). The effect of density on gastric emptying of single and multiple-unit dosage forms. Pharm. Res.3: 208-213.
15. Deshpande AA, Shah NH, Rhodes CT, Malick W. (1997). Development of a novel controlled-release system for gastric retention. Pharm. Res.14:815-819.
16. Foster R, Plosker G. Glipizide: A Review of the Pharmacoeconomic Implications of the Extended-Release Formulation in Type 2 Diabetes Mellitus. PharmacoEconomics. 18 (3): 2000; 289-306.
17. Gan-Lin C, Wei-Hua H. (1998). In vitro performance of floating sustained release capsule of verapamil. Drug Dev. Ind. Pharm., 24(11):1067-1072.
18. 2 and Sd for the development of diltiazem HCl modified-release tablets using a 32 factorial design. Drug Dev. Ind. Pharm., 28(1):77-87.
19. Gupta A, Garg S, Khar RK. (1992). Measurement of bioadhesive strength of muco-adhesive buccal tablets: design of an in vitro assembly. Indian drugs.. 30:152-155.
20. Korsmeyer RW, Peppas NA. (1983). Macromolecular and modeling aspects of swelling controlled systems. In Controlled Release Delivery Systems, eds. Roseman, T.J., and Mansdorf, S.Z. New York: Marcel Dekker, pp 77-90.
21. Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. (1992). In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J Pharm.,78: 43-48.
22. Li S, Lin S, Daggy BP. (2002). Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev. Ind.Pharm., 28(7):783-793.
23. Li S, Lin S, Daggy BP. (2003). Effect of HPMC and carbopol on the release and floating properties of gastric floating drug delivery system using factorial design. Int. J. Pharm., 253:13-22.
24. Mamajek RC, Moyer ES. (1980). Drug-dispensing device and method. US Patent 4, 207, 890.
25. Menger C, Lone K, William C, Tamara S, Michael M, Rochelle H. (2002). Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes mellitus. Journal of clinical pharmacology. 42(6): pp 651-657.
26. Mitchell K, Ford JL, Armstrong DJ. (1993). The influence of concentration on the release of drugs from gels a matrices controlling Methocel. Int. J. Pharm. 100:155-163.
27. Muller-Lissner SA, Blum AL. (1981). The effect of specific gravity and eating on gastric emptying of slow-release capsules. New Engl. J. Med. 304:1365-1366.
28. Patel JK, Patel R, Amin AF, Patel M. (2005). Formulation and evaluation of mucoadhesive glipizide microspheres. AAPS Pharm. Sci. Tech., 6(1): E49-E55.
29. Patel JK, Chavda JR. (2009). Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy. J Microencapsulation. 26(4): 365-376.
30. Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60:110-111.
31. Peppas NA, Wright SL. (1998). Drug diffusion and binding in ionizable interpenetrating networks from poly(vinyl alcohol) and poly(acrylic acid). Eur. J. Pharm. Biopharm., 46:15-29.
32. Ponchel G, Irache JM. (1998). Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Del. Rev. 34:191-219.
33. Raval J, Patel J, Nai-Hong Li, Patel M. (2007). Ranitidine hydrochloride floating matrix tablets based low-density polymer: effects of formulation and processing parameters on drug release. Asian Journal of Pharmaceutical Sciences,. 2(4): 146-158.
34. Rao SB, Sharma CP. (1997). Use of chitosan as biomaterial: studies on its safety and hemostatic potential. J. Biomed Mater Res. 34: 21-28.
35. Ritschel WA. (1991). Targeting in the gastrointestinal tract: new approaches, Metods Find. Exp. Clin. Pharmacol,. 13: 313-316.
36. Rubinstein A, Friend DR. (1994). Specific delivery to the gastrointestinal tract. In Polymeric Site-Specific Pharmacotherapy, ed. Domb, A. J. Chichester: Wiley, pp 283-285.
37. Shah N, Zhang G, Apelian V, Zeng. (1993). Prediction of drug release from hydroxypropyl methylcellulose (HPMC) matrices: effect of polymer concentration. Pharm. Res,. 10:1693-1695.
38. Siepmann J, Streuble A, Peppas NA. (2002). Understanding and predicting drug delivery from hydrophilic matrix tablets using the "sequential layer" model. Pharm. Res., 19:306-314.
39. Singh BN, Kim KH. (2000). Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Control. Rel. 63:235-259.
40. Streubel A, Siepmann J, Bodmeier R. (2003). Floating matrix tablets based on low-density foam powder: effects of formulation and processing parameters on drug release. Eur. J. Pharm. Sci., 18(1):37-45.
41. The United States Pharmacopeial Convention. (2003). The United States Pharmacopeia.XXVI. Rockville, MD: United States Pharmacopeial Convention, Inc; 2528.
42. Thombre AG, Denoto AR, Gibbes DC. (1999). Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients. J Control Release. 60: 333-341.
43. Urquhart J, Theeuwes F. (1984). Drug delivery system comprising a reservoir containing a plurality of tiny pills, U.S. patent 4, 434, 153, February 28.
44. Varshosaz J, Tavakoli N, Roozbahani F. (2006). Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended-release tablets. Drug Delivery. 13(4): 277-285.
45. Wilson CG, Washington N. (1989). The stomach: its role in oral drug delivery. In Physiological Pharmaceutics: Biological Barriers to Drug Absorption, ed. Rubinstein, M. H. Chichester: Ellis Horwood, 47-70.
46. Yang L, Fassihi R. (1997). Examination of drug solubility, polymer types, hydrodynamics and loading dose on drug release behaviour from a triplelayer asymmetric configuration delivery system. Int. J. Pharm. 155:219-229.
47. Yang L, Eshraghi J, Fassihi R. (1999). A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitroevaluation. J. Control. Rel. 57: 215-222.